Skip to main content
NIH funding notice PA-14-102

Innovative Technologies and Assays in Support of HIV Cure Research (ITAS-Cure) (R41/R42)

Closed on January 7, 2017.

Posted
February 13, 2014
Close date
January 7, 2017
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $242,204 in first-year total cost, median $242,204.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 AARR-E (81)]1

Most frequent institutions

  1. JAN BIOTECH, INC.1
Competing awards under PA-14-102 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2015Real-Time Spliced-RNA Detection to Quantify Latent HIV-Infected Cells in HAART Patients1R41AI116358-01A1HUIE, JANET LPUTNAM, DAVID AJAN BIOTECH, INC., NY$242,204ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PA-14-102: Innovative Technologies and Assays in Support of HIV Cure Research (ITAS-Cure) (R41/R42) | ScienceDex | ConductScience